Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 59-64 , 15 September 2002

Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy type 1

  • Antonio Mammarella

      Affiliations

    • Department of Medical Therapy, University of Rome “La Sapienza”, Viale Del Policlinico, 155, 00184 Rome, Italy
    • ,
  • Patrizia Ferroni

      Affiliations

    • Department of Experimental Medicine and Pathology, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Michele Paradiso

      Affiliations

    • Department of Medical Therapy, University of Rome “La Sapienza”, Viale Del Policlinico, 155, 00184 Rome, Italy
    • ,
  • Francesca Martini

      Affiliations

    • Department of Experimental Medicine and Pathology, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Vincenzo Paoletti

      Affiliations

    • Department of Medical Therapy, University of Rome “La Sapienza”, Viale Del Policlinico, 155, 00184 Rome, Italy
    • ,
  • Stefania Morino

      Affiliations

    • Department of Neurological Sciences, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Giovanni Antonini

      Affiliations

    • Department of Neurological Sciences, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Pier Paolo Gazzaniga

      Affiliations

    • Department of Experimental Medicine and Pathology, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Antonino Musca

      Affiliations

    • Department of Medical Therapy, University of Rome “La Sapienza”, Viale Del Policlinico, 155, 00184 Rome, Italy
    • ,
  • Stefania Basili

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39-6-49970813; fax: +39-6-49972436
    • Department of Medical Therapy, University of Rome “La Sapienza”, Viale Del Policlinico, 155, 00184 Rome, Italy

Received 8 February 2002 ,Revised 19 April 2002 ,Accepted 4 June 2002.

References 

  1. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc. Res. 1997;33:13–22
  2. The International Myotonic Dystrophy Consortium (IDMC) . New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology. 2000;54:1218–1221
  3. Brook JD, McCurrach ME, Harley HG, et al.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 1992;68:799–808
  4. Fu YH, Pizzuti A, Fenwick RG, et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256–1258
  5. Mahadevan M, Tsilfidis C, Sabourin L, et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255:1253–1255
  6. Harper PS. Myotonic dystrophy. 3rd ed.. London: W.B. Saunders; 2001;
  7. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658–1662
  8. Tracey KJ, Morgello S, Koplin B, Fahey TJ, Fox K, Aledo A. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute cachexia. J. Clin. Invest. 1990;86:2014–2024
  9. Porreca E, Guglielmi DMI, Uncini A, et al.  Haemostatic abnormalities, cardiac involvement, and serum tumor necrosis factor levels in X-linked dystrophic patients. Thromb. Haemost. 1999;81:543–546
  10. Fernandez-Real JM, Molina A, Broch M, et al.  Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes. 1999;48:1108–1112
  11. Petrovsky N, McNair P, Harrison LC. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine. 1998;10:307–312
  12. Johansson A, Carlstrom K, Ahren B, et al.  Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy. J. Clin. Endocrinol. Metab. 2000;85:3169–3176
  13. Baumgarten G, Knuefermann P, Mann DL. Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc. Med. 2000;10:216–223
  14. Dinarello CA, Pomerantz BJ. Proinflammatory cytokines in heart disease. Blood Purif. 2001;19:314–321
  15. Kovick RB, Fogelman AM, Abbasi AS, Peter JB, Pearce ML. Echocardiographic evaluation of posterior left ventricular wall motion in muscular dystrophy. Circulation. 1975;52:447–454
  16. Perloff JK, Stevenson WG, Roberts NK, Cabeen W, Weiss J. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am. J. Cardiol. 1984;54:1074–1081
  17. Nguyen HH, Wolfe JT, Holmes DR, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy. J. Am. Coll. Cardiol. 1988;11:662–671
  18. Tanaka N, Tanaka H, Takeda M, Nimura T, Kanehisa T, Terashi S. Cardiomyopathy in myotonic dystrophy: a light and electron microscopic study of the myocardium. Jpn. Heart J. 1973;14:202–212
  19. Ludatscher RM, Kerner H, Amikan S, Gellei B. Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle. J. Clin. Pathol. 1978;31:1057–1064
  20. Motta J, Guilleminault C, Billingham M, Barry W, Mason J. Cardiac abnormalities in myotonic dystrophy: electrophysiologic and histopathologic studies. Am. J. Med. 1979;67:467–473
  21. Fragola PV, Calò L, Antonini G, et al.  Signal-averaged electrocardiography in myotonic dystrophy. Int. J. Cardiol. 1995;50:61–68
  22. Hiromasa S, Ikeda T, Kubota K, et al.  Ventricular tachycardia and sudden death in myotonic dystrophy. Am. Heart J. 1988;115:914–915
  23. Child JS, Perloff JK. Myocardial myotonia in myotonic muscular dystrophy. Am. Heart J. 1995;129:982–990
  24. Fragola PV, Calo L, Luzi M, Mammarella A, Antonini G. Doppler echocardiographic assessment of left ventricular diastolic function in myotonic distrophy. Cardiology. 1997;88:498–502
  25. Melacini T, Buja G, Fasoli G, et al.  The natural history of cardiac involvement in myotonic dystrophy: an 8-year follow-up in 17 patients. Clin. Cardiol. 1988;11:231–238
  26. Higham PD, Campbell RWF. QT dispersion. Br. Heart J. 1994;71:508–510
  27. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation. 1981;64:235–242
  28. Breithardt G, Cain ME, El-Sherif N, et al.  Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. Circulation. 1991;83:1481–1488
  29. Milner MR, Hawley RJ, Jachim M, Lindsay J, Fletcher RD. Ventricular late potentials in myotonic dystrophy. Ann. Intern. Med. 1991;115:607–613
  30. Melacini P, Villanova C, Menegazzo E, et al.  Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J. Am. Coll. Cardiol. 1995;25:239–245
  31. Dabrowski A, Kramarz E, Piotrowicz R. Dispersion of QT interval in premature ventricular beats as a marker of susceptibility to arrhythmic events. J. Cardiovasc. Risk. 1998;5:97–101
  32. Bornstein NM, Zahavi M, Korczyn AD, Zahavi J. Increased platelet aggregation and release reaction in myotonic dystrophy. J. Neurol. Sci. 1988;84:239–246
  33. Schapira AH, Hutton RA. Platelet aggregation in myotonia. J. Neurol. Sci. 1985;71:351–357
  34. Li YY, Feng YQ, Kadokami T, et al.  Myocardial extracellular matrix remodelling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc. Natl. Acad. Sci. U. S. A. 2000;97:12746–12751
  35. Simson MB, Untereker WJ, Spielman SR, et al.  Relation between late potentials on the body surface and directly recorded fragmented electrocardiograms in patients with ventricular tachycardia. Am. J. Cardiol. 1983;51:105–112
  36. Clark NR, Kelion AD, Nixon J, Hilton-Jones D, Forfar JC. Does cytosine–thymine–guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?. Heart. 2001;86:411–416

PII: S0022-510X(02)00193-4

Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 59-64 , 15 September 2002

Article Tools

* Image Usage & Resolution